Cached score snapshot
US.ZBH · Zimmer Biomet
110分制 60.5/110;5D動能v2 19/50;排序分 79.5/160
Score breakdown
觀望
Score and price trend
Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.
Move the mouse over the chart lines to inspect readings.
- Main score
- 5D momentum v2
- Candlestick
- Historical projection
- Score turn
- Setup grade
| Model | Median | P25/P75 | 歷史相似情境上漲比例 | Down5 | Actual / compare |
|---|---|---|---|---|---|
| Rolling DOE best | -0.40% | -2.47% / +1.64% | 45.2% | 8.2% | Actual +0.75% · vs median +1.15% · inside 25-75 band |
| 30D observation | +2.85% | -3.41% / +9.34% | 61.8% | 18.6% | Actual outcome pending · 1 / 30 bars observed |
| Historical projection 10D n=160 | -0.17% | -2.01% / +2.35% | 45.6% | 6.9% | Actual outcome pending · 1 / 10 bars observed |
歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。
2026-03-30 → 2026-08-05 · 481 archived points · 2 Improving turn signal · 5 Deteriorating signal
Summary
score_with_momentum_v2 = main score + 5D momentum v2
Rolling setup rating
Setup quality, historical edge, and risk are combined into a rolling S/A/B/C/D/F grade for this snapshot date.
Score turn monitor
Has the score quality changed?
Run more market refreshes to build enough archived points for a turn check.
Signals
技術信號 21.8 · 資金流 13.2 · 5D動能v2 19 · VCP PASS
INSTITUTIONAL_DATA_OPTIONAL: Institutional ownership unavailable; neutral money-flow treatment used. FMP_INSTITUTIONAL_FAILED: FMP HTTP 402
Audit trace
Full calculation detail
Calculation detail · 8 sections
Market inputs
Metrics snapshot
110-point main rating
基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10
基本面 — 2.5/5 · 較差
Sub-items
資金流 — 13.2/20 · 一般
Sub-items
institutional
details
warning
市場環境 — 11.6/15 · 良好
Sub-items
vix
details
trend
details
qqq
spy
催化劑 — 2/20 · 較差
Sub-items
catalyst
details
風險管理 — 7.4/10 · 良好
Sub-items
position
details
stopLevels
strength_details
diversification
details
技術信號 — 21.8/30 · 良好
Sub-items
vcpPayload
vcp_metrics
情緒分析 — 2/10 · 較差
Sub-items
sentiment
details
sentimentData
Dimension contribution
5D momentum v2 breakdown
Cursor_18.25 5D momentum v2 0-50
Risk management
position
details
stopLevels
strength_details
diversification
details
Calculation audit log
基本面分析總分: 2.5/5分 資金流分析總分: 13.2/20分 市場環境分析總分: 11.6/15分 催化劑分析: 2/20分 風險管理總分: 7.4/10分 技術信號分析總分: 21.8/30分 情緒分析: 2/10分 共振率(僅顯示不加分): 0%
Technical indicators
adx
atr
cci
cmf
kdj
mfi
obv
rsi
sar
ma50
macd
vwap
volume
derived
ma_cross
bollinger
rsi_short
macd_short
volume_ratio
Raw calculation JSON
{
"risk": {
"level": "Medium",
"reason": "risk management score >= 6.5/10",
"position": {
"score": 1.4,
"details": {
"atrPct": 2.4388250883392226,
"turnoverUsdM": 185.50645472,
"liquidityPoints": 0.4,
"volatilityPoints": 1
}
},
"rrPoints": 1.6,
"stopLevels": {
"symbol": "US.ZBH",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 86.1428,
"strength_details": {
"ma_score": 1,
"atr_score": 2,
"rsi_score": 3,
"macd_score": 3,
"volume_score": 1
},
"market_adjustment": 1,
"risk_reward_ratio": 1.5,
"stop_loss_percent": 4.9,
"take_profit_price": 97.2005,
"target_multiplier": 2.2,
"technical_strength": 2.05,
"take_profit_percent": 7.3
},
"positionPoints": 1.4,
"stopLossPoints": 2.4,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.4966222946663044,
"stopLossPercent": 4.877650176678445,
"diversificationPoints": 2
},
"total": {
"max": 160,
"result": 79.5,
"formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
"baseScore": 60.5,
"modelVersion": "cursor_18_27_news_v2_160",
"momentum5dScore": 19
},
"market": {
"ma20": 86.606,
"ma50": 86.723,
"close": 90.56,
"prevClose": 87.57,
"avgVolume20": 2238002,
"volumeRatio": 0.92,
"changePercent": 3.41
},
"sources": {
"catalyst": "finnhub_news_keyword_model",
"sentiment": "finnhub_news_keyword_model",
"fundamentals": "fmp_stable",
"institutional": null,
"marketContext": "twelvedata+fred"
},
"barCount": 60,
"momentum": {
"max": 50,
"result": 19,
"details": {
"ret_5d": 0.013769170491436222,
"max_score": 50,
"max_total": 50,
"raw_total": 19,
"vcp_bonus": 2,
"vol_ratio": 0.9148013924522657,
"ret_points": 4,
"vol_points": 0,
"range_ratio": 1.1739234081649106,
"volat_points": 0,
"day_range_pct": 0.028268584363957537,
"model_version": "cursor_18_27_news_v2_160",
"available_bars": 30,
"breakout_points": 8,
"partial_history": false,
"pullback_points": 1,
"breakout_vol_bonus": 0,
"first_breakout_20d": true,
"return_window_days": 5,
"first_breakout_bonus": 2,
"breakout_quality_points": 2
},
"formula": "Cursor_18.25 5D momentum v2 0-50",
"modelVersion": "cursor_18_27_news_v2_160"
},
"scoreMax": 110,
"composite": {
"max": 160,
"result": 79.5,
"formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
"weights": [
{
"raw": 2.5,
"label": "基本面",
"weight": "5/110",
"normalized": 50,
"contribution": 2.5
},
{
"raw": 13.2,
"label": "資金流",
"weight": "20/110",
"normalized": 66,
"contribution": 13.2
},
{
"raw": 11.6,
"label": "市場環境",
"weight": "15/110",
"normalized": 77.33,
"contribution": 11.6
},
{
"raw": 2,
"label": "催化劑",
"weight": "20/110",
"normalized": 10,
"contribution": 2
},
{
"raw": 7.4,
"label": "風險管理",
"weight": "10/110",
"normalized": 74,
"contribution": 7.4
},
{
"raw": 21.8,
"label": "技術信號",
"weight": "30/110",
"normalized": 72.67,
"contribution": 21.8
},
{
"raw": 2,
"label": "情緒分析",
"weight": "10/110",
"normalized": 20,
"contribution": 2
}
],
"modelVersion": "cursor_18_27_news_v2_160"
},
"momentumMax": 50,
"scoreStatus": "checked",
"standard110": {
"rating": "觀望",
"result": 60.5,
"details": [
"基本面分析總分: 2.5/5分",
"資金流分析總分: 13.2/20分",
"市場環境分析總分: 11.6/15分",
"催化劑分析: 2/20分",
"風險管理總分: 7.4/10分",
"技術信號分析總分: 21.8/30分",
"情緒分析: 2/10分",
"共振率(僅顯示不加分): 0%"
],
"formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
"dimensionScores": {
"催化劑": 2,
"基本面": 2.5,
"資金流": 13.2,
"市場環境": 11.6,
"情緒分析": 2,
"技術信號": 21.8,
"風險管理": 7.4
},
"dimensionDetails": {
"催化劑": {
"max": 20,
"grade": "較差",
"items": {
"catalyst": {
"score": 2,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 7,
"catalystCount": 0
}
},
"catalystPoints": 2
}
},
"基本面": {
"max": 5,
"grade": "較差",
"items": {
"pbPoints": 0.5,
"pePoints": 0.4,
"epsPoints": 0,
"roePoints": 0,
"debtPoints": 0.4,
"marginPoints": 0,
"turnoverUsdM": 185.50645472,
"volumePoints": 0.5,
"revenuePoints": 0,
"dividendPoints": 0.3,
"marketCapPoints": 0.4
},
"source": "fmp_stable"
},
"資金流": {
"max": 20,
"grade": "一般",
"items": {
"cmfPoints": 0.8,
"mfiPoints": 4,
"obvPoints": 2.4,
"vwapPoints": 4,
"institutional": {
"score": 2,
"details": {
"source": "optional-neutral",
"warning": {
"code": "INSTITUTIONAL_DATA_OPTIONAL",
"symbol": "US.ZBH",
"message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
},
"optional": true,
"holderCount": null,
"holderPoints": 2,
"top10ShareRatio": null,
"concentrationPenalty": 0
}
},
"institutionPoints": 2
}
},
"市場環境": {
"max": 15,
"grade": "良好",
"items": {
"vix": {
"score": 1.8,
"details": {
"source": "twelvedata+fred",
"vixClose": 19.49
}
},
"trend": {
"score": 2.8,
"details": {
"qqq": {
"ma20": 726.8700022500002,
"ma50": 699.6553995000002,
"name": "QQQ",
"close": 710.62,
"points": 1.4
},
"spy": {
"ma20": 745.6905002499999,
"ma50": 732.9736006400001,
"name": "SPY",
"close": 733.23999,
"points": 1.4
},
"source": "twelvedata+fred"
}
},
"atrPct": 2.4388250883392226,
"atrPoints": 3,
"cciPoints": 4,
"vixPoints": 1.8,
"marketTrendPoints": 2.8
}
},
"情緒分析": {
"max": 10,
"grade": "較差",
"items": {
"sentiment": {
"score": 2,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 7,
"negativeHits": 2,
"positiveHits": 2,
"sentimentScoreRaw": 0
}
},
"sentimentData": {
"raw": [
{
"id": 140715814,
"url": "https://finnhub.io/api/news?id=36eb28a8270750c86ed8bc23e2ca5708f0ab83df06a973b054459d97cfe0c8fd",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.",
"category": "company",
"datetime": 1782314640,
"headline": "ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?"
},
{
"id": 140602225,
"url": "https://finnhub.io/api/news?id=9fe49e482bc56bb05f6d592cd872efd951762204c6033e9b9fab15984cbee012",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Zimmer Biomet Holdings currently sits with no changes to its published price targets, so you are working with the same reference points that were already in place. With no fresh analyst commentary on record, recent market moves are not being framed by new Wall Street narratives. Read on to see how you can track future revisions and keep up with how the story around this stock evolves over time. Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to...",
"category": "company",
"datetime": 1781137165,
"headline": "Why The Narrative Around Zimmer Biomet (ZBH) Is Shifting Without New Analyst Updates"
},
{
"id": 140581614,
"url": "https://finnhub.io/api/news?id=e807ea147c809c9a05caecce5563b33b2635da17565f7f169c1e40b8dcce745a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Is ZBH a good stock to buy? We came across a bullish thesis on Zimmer Biomet Holdings, Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ZBH. Zimmer Biomet Holdings, Inc.’s share was trading at $87.27 as of June 8th. ZBH’s trailing and forward P/E were 22.62 and 10.46 respectively according […]",
"category": "company",
"datetime": 1781015440,
"headline": "Is Zimmer Biomet Holdings, Inc. (ZBH) A Good Stock To Buy Now?"
},
{
"id": 140573692,
"url": "https://finnhub.io/api/news?id=3c731df515e487f63c0aeca355fc5c45231f7a5fdfaa49df13f31c359af95d84",
"image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"source": "SeekingAlpha",
"related": "ZBH",
"summary": "Zimmer Biomet Holdings, Inc. (ZBH) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 10:40 AM EDTCompany ParticipantsIvan Tornos -...",
"category": "company",
"datetime": 1780938510,
"headline": "Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript"
},
{
"id": 140447049,
"url": "https://finnhub.io/api/news?id=68e783a1f7d7f1c5f76f949885719c7d67d503b03ffbb9896ce38fb811ebf383",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
"category": "company",
"datetime": 1779982221,
"headline": "Zimmer (ZBH) Up 3.1% Since Last Earnings Report: Can It Continue?"
},
{
"id": 140435001,
"url": "https://finnhub.io/api/news?id=8da8881f1410a134869809e6e5294d0385017ddf3b1d73f443ab41aecd5fc04d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Over the past six months, Zimmer Biomet’s shares (currently trading at $85.45) have posted a disappointing 12.4% loss, well below the S&P 500’s 9.1% gain. This might have investors contemplating their next move.",
"category": "company",
"datetime": 1779897204,
"headline": "3 Reasons to Sell ZBH and 1 Stock to Buy Instead"
},
{
"id": 140420479,
"url": "https://finnhub.io/api/news?id=b70082c170e45eb4b50cc25e05c10dae5407ada933d6c97f101e23b60dd0374d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the best robotic surgery stocks to buy. Canaccord cut the price target on Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to $83 from $93 on April 29, and maintained a Buy rating on the shares. The firm stated that the company delivered a solid fiscal Q1 to start the year, […]",
"category": "company",
"datetime": 1779797341,
"headline": "Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy?"
}
],
"raw_source": [
{
"id": 140715814,
"url": "https://finnhub.io/api/news?id=36eb28a8270750c86ed8bc23e2ca5708f0ab83df06a973b054459d97cfe0c8fd",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.",
"category": "company",
"datetime": 1782314640,
"headline": "ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?"
},
{
"id": 140705492,
"url": "https://finnhub.io/api/news?id=1374c0428d1b2f30e94c855825a137bd852b3b4e88be883228e4e073a0ee8595",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "While the market fixates on a disruptive quarter for Stryker stock, the company's powerful ability to convert profit into hard cash reveals a deeper, under-appreciated resilience.",
"category": "company",
"datetime": 1782238309,
"headline": "The Cash-Flow Fortress The Stryker Stock Bears Keep Missing"
},
{
"id": 140671540,
"url": "https://finnhub.io/api/news?id=b85f73c9839ef1c88922e1e344a59e1c8b958316f1c6760961e5524a9583e6e1",
"image": "https://image.cnbcfm.com/api/v1/image/108323633-5ED3-MM-E-BLOCK-061726.jpg?v=1781738910&w=1920&h=1080",
"source": "CNBC",
"related": "ZBH",
"summary": "'Mad Money' host Jim Cramer weighs in on stocks including: Fair Isaac Corporation, Clover Health, Vistra, and Stryker Corporation.",
"category": "company",
"datetime": 1781726833,
"headline": "Lightning Round: I like FICO but I am afraid it's going to be hurt by AI, says Jim Cramer"
},
{
"id": 140643627,
"url": "https://finnhub.io/api/news?id=1cf6cf264296e34cf6aa6b883260c6b94b4448c6df4d5586d01127206df8dadb",
"image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2210914563/image_2210914563.jpg?io=getty-c-w1536",
"source": "SeekingAlpha",
"related": "ZBH",
"summary": "Zimmer Biomet (ZBH) looks undervalued: strong free cash flow, high margins, sales/EPS growth, buybacks and manageable debt. See more details here.",
"category": "company",
"datetime": 1781581929,
"headline": "Zimmer Biomet: Does Slow And Steady Still Win The Race?"
},
{
"id": 140638992,
"url": "https://finnhub.io/api/news?id=55c6e6735b3614e92e560eaa15ab79337321693464dc85a5555a3aab2a2c0302",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Zimmer Biomet has lagged the broader S&P 500 Index over the past year, and analysts remain on the sidelines as they weigh the company's steady fundamentals against its modest growth outlook.",
"category": "company",
"datetime": 1781524151,
"headline": "Is Zimmer Biomet Stock Underperforming the S&P 500?"
},
{
"id": 140613133,
"url": "https://finnhub.io/api/news?id=fa7dc8445299911bf16502caaeab45d89c5c4cbbc69b958e2ee1a72a63a007d6",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Is SOLV a good stock to buy? We came across a bullish thesis on Solventum Corporation on r/ValueInvesting by raytoei. In this article, we will summarize the bulls’ thesis on SOLV. Solventum Corporation’s share was trading at $82.46 as of June 9th. SOLV’s trailing and forward P/E were 10.09 and 12.58 respectively according to Yahoo Finance. Solventum […]",
"category": "company",
"datetime": 1781208796,
"headline": "Is Solventum Corporation (SOLV) A Good Stock To Buy Now?"
},
{
"id": 140602225,
"url": "https://finnhub.io/api/news?id=9fe49e482bc56bb05f6d592cd872efd951762204c6033e9b9fab15984cbee012",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Zimmer Biomet Holdings currently sits with no changes to its published price targets, so you are working with the same reference points that were already in place. With no fresh analyst commentary on record, recent market moves are not being framed by new Wall Street narratives. Read on to see how you can track future revisions and keep up with how the story around this stock evolves over time. Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to...",
"category": "company",
"datetime": 1781137165,
"headline": "Why The Narrative Around Zimmer Biomet (ZBH) Is Shifting Without New Analyst Updates"
},
{
"id": 140581614,
"url": "https://finnhub.io/api/news?id=e807ea147c809c9a05caecce5563b33b2635da17565f7f169c1e40b8dcce745a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Is ZBH a good stock to buy? We came across a bullish thesis on Zimmer Biomet Holdings, Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ZBH. Zimmer Biomet Holdings, Inc.’s share was trading at $87.27 as of June 8th. ZBH’s trailing and forward P/E were 22.62 and 10.46 respectively according […]",
"category": "company",
"datetime": 1781015440,
"headline": "Is Zimmer Biomet Holdings, Inc. (ZBH) A Good Stock To Buy Now?"
},
{
"id": 140581511,
"url": "https://finnhub.io/api/news?id=46db3f2ddb8f68a9fda811f499351527e0ebbe2252337876f92aa9582fde5c35",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "ISRG lifts margins despite tariffs, using scale, cost cuts and da Vinci 5 adoption to offset inflation as 2026 cost pressures build.",
"category": "company",
"datetime": 1781014020,
"headline": "Will ISRG's Cost Leverage Aid Margins Amid Tariff & Input Inflation?"
},
{
"id": 140581528,
"url": "https://finnhub.io/api/news?id=fff801fa2f8f5420353b512baf5d61c8d4ac7e0cb77437df58f4af361c100815",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Globus Medical is riding on musculoskeletal market growth with strong Q1 sales gains, double-digit spine growth, and rising trauma demand across key product lines.",
"category": "company",
"datetime": 1781013660,
"headline": "Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom"
},
{
"id": 140573692,
"url": "https://finnhub.io/api/news?id=3c731df515e487f63c0aeca355fc5c45231f7a5fdfaa49df13f31c359af95d84",
"image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"source": "SeekingAlpha",
"related": "ZBH",
"summary": "Zimmer Biomet Holdings, Inc. (ZBH) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 10:40 AM EDTCompany ParticipantsIvan Tornos -...",
"category": "company",
"datetime": 1780938510,
"headline": "Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript"
},
{
"id": 140538765,
"url": "https://finnhub.io/api/news?id=154616564cbf3982765e3e6bd14f79360db48ccb79cfcda02804e9f0b4f1bb48",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
"category": "company",
"datetime": 1780673427,
"headline": "Why Is Perrigo (PRGO) Down 9% Since Last Earnings Report?"
},
{
"id": 140525761,
"url": "https://finnhub.io/api/news?id=208a7fca9c2fb19fe671ca5b45ad12cb4688fe71c05248efbdeab44509fdb3a9",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Globus Medical's debt-free balance sheet, nearly $630M in liquid assets and strong cash flow give it the flexibility to fund growth and support shareholders.",
"category": "company",
"datetime": 1780588500,
"headline": "Here's How Financial Strength Remains a Key Advantage for GMED"
},
{
"id": 140500624,
"url": "https://finnhub.io/api/news?id=a5e65034a45c9049f09c1511bc42d5210be3019312b0c99d59a2ee7bb47837e4",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Globus Medical is riding musculoskeletal market growth with spine, trauma and ortho gains, strong cash flow and a debt-free balance sheet.",
"category": "company",
"datetime": 1780410540,
"headline": "Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?"
},
{
"id": 140498523,
"url": "https://finnhub.io/api/news?id=dc236427ceaf3d1a5e737ff55f7ddacae7bc6aff8b01ca6eaba9f9f8db94bfe7",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8 with a fireside chat at 10:40 a.m. ET.",
"category": "company",
"datetime": 1780399800,
"headline": "Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference"
},
{
"id": 140497868,
"url": "https://finnhub.io/api/news?id=1e939934e2e5739e9e6c8226ea4e4c29629eca8fb63f3fdd9c03c88d0f1eec9e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.",
"category": "company",
"datetime": 1780394243,
"headline": "2 Profitable Stocks to Consider Right Now and 1 We Question"
},
{
"id": 140460516,
"url": "https://finnhub.io/api/news?id=8087e2bad148885b17ab7dc0369a07e9077ba8fa101ee49c0398193adc357cd4",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "GE HealthCare (GEHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
"category": "company",
"datetime": 1780068606,
"headline": "GE HealthCare (GEHC) Up 3.3% Since Last Earnings Report: Can It Continue?"
},
{
"id": 140451402,
"url": "https://finnhub.io/api/news?id=4d4b45bd859b29d0ba102e343cd5e3952515a884bb0f1e3a10f69952228c51fc",
"image": "",
"source": "Benzinga",
"related": "ZBH",
"summary": "Citigroup analyst Joanne Wuensch maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and lowers the price target from $95 to $93.",
"category": "company",
"datetime": 1779984634,
"headline": "Citigroup Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $93"
},
{
"id": 140447049,
"url": "https://finnhub.io/api/news?id=68e783a1f7d7f1c5f76f949885719c7d67d503b03ffbb9896ce38fb811ebf383",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
"category": "company",
"datetime": 1779982221,
"headline": "Zimmer (ZBH) Up 3.1% Since Last Earnings Report: Can It Continue?"
},
{
"id": 140443709,
"url": "https://finnhub.io/api/news?id=537fbfb375ad4f7d8910fee5a75b0417b01bb38fbd04ce57abd40c92ecf5833b",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destocking have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 1.2% has lagged the S&P 500’s 9.8% climb.",
"category": "company",
"datetime": 1779974307,
"headline": "3 Healthcare Stocks That Fall Short"
},
{
"id": 140435000,
"url": "https://finnhub.io/api/news?id=acc8a51efa459f1e33a2c33e16a16fb62d5c2d9bd360fe0b82bfab958ec4a472",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announces that its TMINI® Miniature Robotic System has been used in its 5,000th total knee (TKA) procedure. The 5,000th case was recently completed by Dr. John Tiberi of Cedars-Sinai Orthopedics in Los Angeles, CA.",
"category": "company",
"datetime": 1779897600,
"headline": "THINK Surgical Announces the TMINI® Miniature Robotic System 5,000th Procedure Milestone"
},
{
"id": 140435001,
"url": "https://finnhub.io/api/news?id=8da8881f1410a134869809e6e5294d0385017ddf3b1d73f443ab41aecd5fc04d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Over the past six months, Zimmer Biomet’s shares (currently trading at $85.45) have posted a disappointing 12.4% loss, well below the S&P 500’s 9.1% gain. This might have investors contemplating their next move.",
"category": "company",
"datetime": 1779897204,
"headline": "3 Reasons to Sell ZBH and 1 Stock to Buy Instead"
},
{
"id": 140420479,
"url": "https://finnhub.io/api/news?id=b70082c170e45eb4b50cc25e05c10dae5407ada933d6c97f101e23b60dd0374d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "ZBH",
"summary": "Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the best robotic surgery stocks to buy. Canaccord cut the price target on Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to $83 from $93 on April 29, and maintained a Buy rating on the shares. The firm stated that the company delivered a solid fiscal Q1 to start the year, […]",
"category": "company",
"datetime": 1779797341,
"headline": "Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy?"
}
],
"data_source": "finnhub_news_keyword_model",
"article_count": 7,
"negative_hits": 2,
"positive_hits": 2,
"recomputed_at_score": true,
"sentiment_score_raw": 0,
"source_article_count": 23,
"discarded_article_count": 16
},
"sentimentPoints": 2
}
},
"技術信號": {
"max": 30,
"raw": 21.8,
"grade": "良好",
"items": {
"bbPoints": 3,
"adxPoints": 3,
"sarPoints": 2.4000000000000004,
"vcpPoints": 3.2,
"macdPoints": 4,
"vcpPayload": {
"vcp_pass": true,
"vcp_score": 3.2,
"vcp_reason": "波幅收縮(12.6%→5%);跌縮量(近10日3日);站上MA50;升放量(近10日2日);收盤突破20日高位;Ready=Y;Confirm=Y",
"vcp_metrics": {
"up_days": 4,
"vol_ref": 2264506.6666666665,
"down_days": 5,
"vcp_ready": true,
"above_ma50": true,
"avg_vol_10": 2302850,
"avg_vol_20": 2239215,
"avg_vol_30": 2264506.6666666665,
"range_pct_10": 0.04958036660777385,
"range_pct_20": 0.09849823321554772,
"range_pct_30": 0.12566254416961126,
"up_expand_ok": true,
"lookback_used": 59,
"near_20d_high": true,
"contraction_ok": true,
"down_shrink_ok": true,
"up_expand_days": 2,
"breakout_20d_ok": true,
"vol_ratio_10_30": 1.0169323119678753,
"dist_to_20d_high": -0.0006629834254143897,
"down_shrink_days": 3,
"breakout_level_20d": 90.5,
"vcp_breakout_confirm": true,
"contraction_ratio_10_30": 0.39455166959578225
},
"vcp_name_en": "Volatility Contraction Pattern",
"vcp_name_zh": "波動收縮形態",
"vol_contraction": true
},
"kdjAdxPoints": 0.8,
"rsiKdjPoints": 3.2,
"volumeWeight": 2,
"maCrossPoints": 0,
"shortRsiPoints": 1,
"shortMacdPoints": 0.4,
"volConfirmPoints": 0,
"volumePointsTechnical": 0.8
}
},
"風險管理": {
"max": 10,
"grade": "良好",
"items": {
"position": {
"score": 1.4,
"details": {
"atrPct": 2.4388250883392226,
"turnoverUsdM": 185.50645472,
"liquidityPoints": 0.4,
"volatilityPoints": 1
}
},
"rrPoints": 1.6,
"stopLevels": {
"symbol": "US.ZBH",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 86.1428,
"strength_details": {
"ma_score": 1,
"atr_score": 2,
"rsi_score": 3,
"macd_score": 3,
"volume_score": 1
},
"market_adjustment": 1,
"risk_reward_ratio": 1.5,
"stop_loss_percent": 4.9,
"take_profit_price": 97.2005,
"target_multiplier": 2.2,
"technical_strength": 2.05,
"take_profit_percent": 7.3
},
"positionPoints": 1.4,
"stopLossPoints": 2.4,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.4966222946663044,
"stopLossPercent": 4.877650176678445,
"diversificationPoints": 2
}
}
}
},
"modelVersion": "cursor_18_27_news_v2_160",
"providerErrors": [],
"rankingScoreMax": 160,
"dataCompleteness": {
"complete": true,
"missingFields": [],
"optionalInputs": [
"institutionalData"
],
"requiredInputs": [
"fundamentals",
"marketContext.VIX",
"marketContext.SPY",
"marketContext.QQQ",
"catalystData",
"sentimentData",
"ATR",
"sector"
],
"optionalInputWarnings": []
},
"technicalIndicators": {
"adx": 85.71,
"atr": {
"atr": 2.2086,
"rule": "ATR / current price; lower volatility scores higher",
"score": 6,
"atr_pct": 2.44
},
"cci": {
"rule": "Cursor_18.24 CCI bands",
"level": "強勢區",
"score": 10,
"value": 99.05
},
"cmf": {
"rule": "Cursor_18.24 CMF bands",
"level": "派發",
"score": 2,
"value": -0.0459
},
"kdj": {
"d": 53.64,
"j": 72.74,
"k": 60.01,
"rule": "Cursor_18.24 K/D cross",
"score": 6,
"signal": "強金叉"
},
"mfi": {
"rule": "Cursor_18.24 MFI bands",
"level": "強資金流入",
"score": 10,
"value": 73.78
},
"obv": {
"rule": "Cursor_18.24 recent_slope vs previous_slope",
"score": 6,
"trend": "有流入",
"value": 12774337,
"recentSlope": 501783.7,
"previousSlope": 776850
},
"rsi": 66.03,
"sar": {
"rule": "Cursor_18.24 Parabolic SAR",
"score": 8,
"trend": "上升",
"value": 86.8267,
"position": "SAR喺價下",
"distancePct": 4.12,
"previousTrend": "上升"
},
"ma50": 86.723,
"macd": {
"macd": 0.8605442462234691,
"trend": "強烈看漲",
"signal": 0.5971726269544396,
"histogram": 0.2633716192690295
},
"vwap": {
"rule": "Cursor_18.24 VWAP 20D consecutive close",
"score": 10,
"value": 86.5344,
"position": "連續5日>VWAP",
"consecutiveAbove": 16
},
"volume": {
"rule": "Cursor_18.24 volume ratio",
"level": "無力",
"ratio": 0.92,
"score": 4,
"avgVolume": 2238002,
"currentVolume": 2048437
},
"derived": {
"ma20": 86.606,
"ma50": 86.723,
"prevClose": 87.57,
"avgVolume10": 2320714,
"avgVolume20": 2238002,
"changePercent": 3.41,
"avgVolumeForScore": 2238002
},
"ma_cross": {
"ma20": 86.606,
"ma50": 86.723,
"rule": "Cursor_18.24 MA20/MA50 cross",
"cross": "熊勢",
"score": 0,
"prevMa20": 86.2985,
"prevMa50": 86.8186,
"spreadPct": 0.13,
"isVolumeBreakout": false
},
"bollinger": {
"lower": 81.7264,
"upper": 91.4856,
"position": "上半部"
},
"rsi_short": 63.69,
"macd_short": {
"macd": 0,
"trend": "中性",
"signal": 0,
"histogram": 0
},
"volume_ratio": {
"ratio": 0.92
}
}
}
Raw metrics JSON
{
"close": 90.56,
"volume": 2048437,
"changePercent": 3.41
}
Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.